These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer]. Author: Hasumi H, Kishida T, Teranishi J, Nakaigawa N, Fujinami K, Ikeda I, Uemura H, Yao M, Takeda M, Noguchi S, Kubota Y. Journal: Hinyokika Kiyo; 2002 Aug; 48(8):469-73. PubMed ID: 12243071. Abstract: Between June 1998 and August 2000, five patients with germ cell tumor were treated with high-dose CEI: carboplatin (1,250 mg/m2), etoposide (1,500 mg/m2), and ifosfamide (7.5 g/m2), followed by peripheral blood stem cell transplantation (PBSCT) at Yokohama City University Hospital. All patients were classified into either poor risk group of International Germ Cell Consensus Classification or advanced extent of Indiana University stage, and received one cycle of high-dose CEI after 4-6 cycles of standard PEB (cisplatin, bleomycin, vinblastin) therapy. Three of the patients achieved complete response, one achieved partial response and one achieved no change after whole treatment. There were no fatal complications and no treatment-related deaths.[Abstract] [Full Text] [Related] [New Search]